MarketWatch

Endoscopic Closure Devices Market to Grow by USD 825.7 Million (2025-2029), Rising Gastrointestinal Disease Cases Drive Growth, AI-Powered Market Evolution - Technavio

NEW YORK, Jan. 3, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global endoscopic closure devices market size is estimated to grow by USD 825.7 million from 2025-2029, ...
Medscape

PROTECT-AF: Device closure of LAA may provide alternative to warfarin to prevent stroke in AF

Results of the Embolic Protection in Patients with Atrial Fibrillation (PROTECT-AF) showed that in AF patients who were candidates for warfarin therapy, device closure of the LAA using the Watchman ...
Morningstar

CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and ...

MARLBOROUGH, Mass. and NEW ORLEANS, March 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary ...
Medscape

Defying Hopes, Dual Antiplatelets May Be Needed With LAA-Closure Devices in AF

VIENNA, AUSTRIA — Thrombi were sometimes found on two left-atrial-appendage (LAA) occluder devices in the weeks following implantation in two large registry studies of patients with atrial ...
Business Wire

Vivasure Announces Positive Results of PATCH IDE Pivotal Study Indicating Safety and Efficacy of PerQseal ® Large Hole Closure Device

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced initial positive results from its U.S. IDE ...